Effect of the Procalcitonin Assay on Antibiotic Use in Critically Ill Children | Zendy

Rachael Ross | Zendy; Luke Keele | Zendy; Sherri Kubis | Zendy; Andrew J. Lautz | Zendy; Adam Dziorny | Zendy; Adam R. Denson | Zendy; Kathleen O’Connor | Zendy; Marianne Chilutti | Zendy; Scott L. Weiss | Zendy; Jeffrey S. Gerber | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of the Procalcitonin Assay on Antibiotic Use in Critically Ill Children

Author(s) -

Rachael Ross,

Luke Keele,

Sherri Kubis,

Andrew J. Lautz,

Adam Dziorny,

Adam R. Denson,

Kathleen O’Connor,

Marianne Chilutti,

Scott L. Weiss,

Jeffrey S. Gerber

Publication year - 2018

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piy004

Subject(s) - procalcitonin , medicine , antibiotics , critically ill , intensive care medicine , intensive care unit , pediatric intensive care unit , clinical practice , antibiotic therapy , pediatrics , sepsis , microbiology and biotechnology , family medicine , biology

We retrospectively studied the effect of introducing procalcitonin into clinical practice on antibiotic use within a large academic pediatric intensive care unit. In the absence of a standardized algorithm, availability of the procalcitonin assay did not reduce the frequency of antibiotic initiations or the continuation of antibiotics for greater than 72 hours.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research